“Tomorrow’s Natural Health Solutions, Today!”
The world has changed, forcing us to rethink our efforts to create safer, natural solutions to mental health disorders. Palantir Bioceuticals is committed to transforming mental health with plant-based assisted psychotherapy.
According to Mental Health America (MHA) Nearly 50M or 19.86% of Americans experience a mental illness in 2019. In 2020, The National Alliance on Mental Illness (NAMI) shows that number increased to 52.9 million, this represents 1 in 5 Americans who have experienced mental illness. Covid-19 has exacerbated the mental health crisis to epidemic proportions. According to the World Health Organization (WHO), mental health disorders affect 700 million people globally.
There is an increased need for solutions to depression, anxiety, addictions, PTSD, and suicide. Palantir Bioceuticals is on a mission to transform mental healthcare. Our goal is to create safe and effective holistic therapeutics for patients to address a multitude of mental health disorders.
Why Palantir Bioceuticals?
Palantir Bioceuticals is an ethical biopharmaceutical publicly traded company offering holistic solutions to mental health illnesses. We positioned Palantir Bioceuticals to meet market growth needs for plant based assisted psychotherapy and committed to transforming mental health. Our goal is to gain medical real estate properties around the country and lease them to management companies committed to natural health and plant based psychotherapy. Palantir Bioceuticals’ first acquisition is a 14 acre, 380,000 square foot hospital facility, making it the first Behavioral Mental Health Hospital in America specializing in plant based medicine. Our business model also facilitates revenue from in house surgical and dialysis centers, and ambulatory services.